Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.
about
Capturing relevant extracellular matrices for investigating cell migrationPeriostin and TGF-β-induced protein: Two peas in a pod?Fibronectin Modulates Cell Adhesion and Signaling to Promote Single Cell Migration of Highly Invasive Oral Squamous Cell CarcinomaExtracellular matrix as target for antitumor therapyComparative proteomic assessment of matrisome enrichment methodologiesThe extracellular matrix: Tools and insights for the "omics" eraBone marrow niche-mimetics modulate HSPC function via integrin signaling.A 3D matrix platform for the rapid generation of therapeutic anti-human carcinoma monoclonal antibodies.Pericellular proteolysis in cancerStructural ECM components in the premetastatic and metastatic niche.Inositol Hexaphosphate and Inositol Inhibit Colorectal Cancer Metastasis to the Liver in BALB/c Mice.Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity.Tumor angiogenesis in the absence of fibronectin or its cognate integrin receptors.Absence of Vitamin K-Dependent γ-Carboxylation in Human Periostin Extracted from Fibrotic Lung or Secreted from a Cell Line Engineered to Optimize γ-Carboxylation.Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution.Enrichment of Extracellular Matrix Proteins from Tissues and Digestion into Peptides for Mass Spectrometry AnalysisProteomic analysis of naturally-sourced biological scaffolds.The Predictive Link between Matrix and Metastasis.Tumor macrophages are pivotal constructors of tumor collagenous matrix.Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.Comprehensive Proteomic Characterization of the Human Colorectal Carcinoma Reveals Signature Proteins and Perturbed Pathways.Recapitulating the human tumor microenvironment: Colon tumor-derived extracellular matrix promotes angiogenesis and tumor cell growth.Identification of Nidogen 1 as a lung metastasis protein through secretome analysis.Identification of Sets of Cytoskeletal Related and Adhesion-related Coding Region Mutations in the TCGA Melanoma Dataset that Correlate with a Negative Outcome.Priming Endothelial Cells With a Melanoma-Derived Extracellular Matrix Triggers the Activation of αvβ3/VEGFR2 Axis.Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior?Identification of FERM domain-containing protein 5 as a novel target of β-catenin/TCF7L2 complex.Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironments.Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients.Overlap of the cancer genome atlas and the immune epitope database.Unique insight into microenvironmental changes in colorectal cancer: Ex vivo assessment of matrix metalloprotease-mediated molecular changes in human colorectal tumor tissue and corresponding non-neoplastic adjacent tissue.Detection of extracellular matrix modification in cancer models with inverse spectroscopic optical coherence tomographyQuantitative extracellular matrix proteomics to study mammary and liver tissue microenvironments.Microfluidic-Based Generation of 3D Collagen Spheres to Investigate Multicellular Spheroid Invasion.Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes.Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.Engineering Breast Cancer Microenvironments and 3D Bioprinting.Sleeping Beauty and the Microenvironment Enchantment: Microenvironmental Regulation of the Proliferation-Quiescence Decision in Normal Tissues and in Cancer Development.Individualized predictive signatures for 5-fluorouracil-based chemotherapy in right- and left-sided colon cancer.Genome-scale analysis identifies SERPINE1 and SPARC as diagnostic and prognostic biomarkers in gastric cancer
P2860
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
P248
Q26766161-A82C7B7A-04D0-4AB5-9267-553D496EEED0Q26796543-7EB83BB5-2889-4805-87F6-3CF7060B1462Q27317356-B23911AB-B0A8-4FAC-ADA2-A1ECBE043E18Q28082018-4E835986-2173-4C6B-B8FE-6BF91DB46049Q28822150-2466C258-51A9-440A-9085-A4021D986903Q28831183-A2EE367E-7A3F-4A41-9213-31CDD5337596Q30854127-4317C256-8EE9-4E73-B9F1-F34788946B18Q34384042-2A611943-B2B0-4D57-BED5-7D054A682ED4Q34430691-26128A7B-9F0E-4295-9482-962AE5B27A1FQ34521147-BB0D6158-B4E2-4B24-9CFA-E1F1725F4BA5Q34526929-ECE74B3E-01D5-4AA8-A591-D85DE7F5E3E8Q35153559-924FD432-BBEC-4AB4-AD42-32948DA5111AQ35217119-97952624-5FDC-43B8-9D55-0CAFA449C36AQ35745864-34411828-AA1B-46AB-A4DC-584331A63045Q35964516-05A541BC-8868-4C5B-ACCF-2D09FE638382Q35983435-BB07A772-49AA-4210-B614-8110F987BFB3Q36278956-A79659F8-8226-42CF-84AE-F135069E9FA3Q36629747-D568F3DF-C8BE-4F83-AA42-14BFE0DB88E0Q37346644-003AD29E-4348-41BA-B6C7-E13E868A18D9Q37575966-2EECC0F4-75C6-4C92-A613-C4B001918E65Q37633338-86E9AF9A-B07C-47EC-A518-22467387353AQ38406450-A6C15663-2704-45EB-8516-F87CC757BBB0Q38615448-EB65C4C4-2572-49A2-B34B-8281FF12B59FQ38703661-906A3B22-DB32-49FF-9F24-49FAD80ABDD7Q38758000-681FDD7B-4F92-42EF-8A07-024DB35ADBAEQ38989294-C1F05469-C9B3-48FE-9869-2B202F32F0BBQ39002280-637D76E0-C2DD-44A4-B94F-4C66D07758DEQ39304713-0060EBA5-2892-4040-8853-939C3C510F89Q39553253-27248E64-6E9E-40AF-B14B-0D1AD26A1CB7Q41198310-4ECFE089-C128-421D-BA72-BF7FD24F747FQ42143202-044B45FF-0CCD-4BE0-BC94-A8F4A70332B0Q42162348-B09F6D69-5475-4656-A5CD-95DE19F283E6Q44638329-AB56C280-2E37-45A5-839A-76D5A019E11CQ46080184-C1A4C290-9E08-46C1-9D44-F6A4D0C88232Q47406043-4D0A4F6E-CB2B-4CB9-986C-36F58D25E24CQ48361512-26BF8733-03EE-4CBD-8C0E-115F1756FFF6Q55001892-4FB10702-6AAC-431F-8E74-6DA1EC2760B9Q55214898-A9DE473F-0B13-42CF-838F-3AC65F48BCA0Q55315465-4D10882C-38E7-4314-A4DC-2A192843F69DQ58565340-7381A5E6-9796-4190-A3B1-830334AD6AB3
P2860
Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Extracellular matrix signature ...... and their metastases to liver.
@ast
Extracellular matrix signature ...... and their metastases to liver.
@en
Extracellular matrix signature ...... and their metastases to liver.
@nl
type
label
Extracellular matrix signature ...... and their metastases to liver.
@ast
Extracellular matrix signature ...... and their metastases to liver.
@en
Extracellular matrix signature ...... and their metastases to liver.
@nl
prefLabel
Extracellular matrix signature ...... and their metastases to liver.
@ast
Extracellular matrix signature ...... and their metastases to liver.
@en
Extracellular matrix signature ...... and their metastases to liver.
@nl
P2093
P2860
P356
P1433
P1476
Extracellular matrix signature ...... and their metastases to liver
@en
P2093
Charles A Whittaker
Kenneth K Tanabe
Richard O Hynes
Steven A Carr
P2860
P2888
P356
10.1186/1471-2407-14-518
P407
P577
2014-07-18T00:00:00Z
P5875
P6179
1034422957